To gain insight into the molecular mechanisms involved in antibiotic resistance shown by Gram-negative bacteria. Bacterial infections can strike anyone and usually the body's immune system, which is designed to fight infection, defeats the invading bacteria. Sometimes however, the burden of infection proves too great, so these infections can prove fatal. For 50 years, we have relied on antibiotics to successfully treat the majority of common bacterial infections. As a result, emphasis must be pl ....To gain insight into the molecular mechanisms involved in antibiotic resistance shown by Gram-negative bacteria. Bacterial infections can strike anyone and usually the body's immune system, which is designed to fight infection, defeats the invading bacteria. Sometimes however, the burden of infection proves too great, so these infections can prove fatal. For 50 years, we have relied on antibiotics to successfully treat the majority of common bacterial infections. As a result, emphasis must be placed on the disquieting reality whilst enjoy the use of antibiotics, an inescapable cost is the development of bacterial resistance. The increasing prevalence of bacterial tolerance against beta-lactams is a problem and as a result is a most pressing health issue. Read moreRead less
DYRK1A As A Novel Target For Glioblastoma Therapies
Funder
National Health and Medical Research Council
Funding Amount
$620,294.00
Summary
Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called DYRK1A (using ‘DYRK1A inhibitors’) kills glioblastoma cells. This therapeutic advantage is even greater when combined with drugs approved for other cancers. This project will develop new DYRK1A inhibitors and examine a novel combination treatment for glioblastoma patients. This could initiate a novel therapy that could significantly extend patients’ lives.
Pharmacology Of Potential Anti-Tumour Agents: Iron Chelators Of The BpT Class
Funder
National Health and Medical Research Council
Funding Amount
$585,455.00
Summary
Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class Cancer cells have a high iron requirement for DNA synthesis and many clinical trials showed Fe chelators are effective anti-cancer drugs. Their potential to act as anti-tumour agents has been confirmed by the entrance of Triapine into widespread NCI clinical trials. In this NHMRC Renewal, we will perform pharmacological and preclinical studies to promote the development of BpT chelators as novel anti-tumour agents.
Structural and Biological Chemistry of Marine Natural Products. Australia's unique marine biodiversity provides a source of novel biologically active compounds with potential for development as pharmaceuticals. This program seeks to explore the structural and biological chemistry of novel marine compounds from marine invertebrates and to evaluate their potential benefit is training of scientists in organic and biological chemistry and advancement of drug-discovery from Australian biodiversity.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0989374
Funder
Australian Research Council
Funding Amount
$550,000.00
Summary
South Australian High-Resolution and Ion-Mobility Mass Spectrometry Facility. The analytical facility will enhance (i) fundamental research to understand the mechanisms of the reactions of charged species with neutral molecules, and (ii) the provision of structural information, including the precise atomic composition of any molecule, small or large. Research supported by this facility includes (a)nanotechnology, including supramolecular chemistry, (b) bioscience: cancer research, neurodegenera ....South Australian High-Resolution and Ion-Mobility Mass Spectrometry Facility. The analytical facility will enhance (i) fundamental research to understand the mechanisms of the reactions of charged species with neutral molecules, and (ii) the provision of structural information, including the precise atomic composition of any molecule, small or large. Research supported by this facility includes (a)nanotechnology, including supramolecular chemistry, (b) bioscience: cancer research, neurodegenerate diseases (e.g. Parkinson's disease) osteoarthritis, inflammation, cardiac diseases and synthetic approaches to anticancer and other drugs.Read moreRead less
Investigation of the metabolism, molecular targets and environmental fate of the seed germination stimulant, butenolide. The potent germination stimulant, known as butenolide, is expected to provide substantial benefits for improving seed germination and seedling vigour of many plant species used in agriculture, land restoration and rehabilitation. Currently, little is known about the stability, persistence and distribution of the butenolide in natural environments and the mechanism of seed dorm ....Investigation of the metabolism, molecular targets and environmental fate of the seed germination stimulant, butenolide. The potent germination stimulant, known as butenolide, is expected to provide substantial benefits for improving seed germination and seedling vigour of many plant species used in agriculture, land restoration and rehabilitation. Currently, little is known about the stability, persistence and distribution of the butenolide in natural environments and the mechanism of seed dormancy breaking. This study now provides a unique opportunity for Australian research to establish a world-leading position in understanding the processes that regulate seed dormancy, particularly in relation to post-mining land rehabilitation. The research findings will also have wider application in plant conservation, weed control and crop production.Read moreRead less
Indian Sandalwood: genetic and oil diversity, and oil biochemistry of the Australian germplasm collection. The main aim is to improve the commerciality of the sandalwood industry in tropical Australia through smarter tree selection and breeding by development of knowledge of oil quality and quantity, oil biochemistry and DNA marker-assisted selection of the germplasm collection available in Australia.
Synthesis and evaluation of labelled germination stimulants for determining the role of butenolide in promoting seed germination. The discovery of the germination promotive agent in smoke (a butenolide) represents a major and internationally significant scientific discovery for Australia and provides exciting opportunities for benefits in agriculture, natural lands management and restoration sciences. The activity demonstrated with a broad range of species shows that the butenolide has general a ....Synthesis and evaluation of labelled germination stimulants for determining the role of butenolide in promoting seed germination. The discovery of the germination promotive agent in smoke (a butenolide) represents a major and internationally significant scientific discovery for Australia and provides exciting opportunities for benefits in agriculture, natural lands management and restoration sciences. The activity demonstrated with a broad range of species shows that the butenolide has general applicability worldwide. This study now provides a unique opportunity for Australian research to establish a world-leading position in understanding the butenolide mode of action within plant seeds which will result in a significant advance in our understanding of the processes that regulate seed dormancy in many plant species. Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100125
Funder
Australian Research Council
Funding Amount
$330,000.00
Summary
Oxidative stress bioanalytical facility. The primary national benefit of this application is that it will provide a currently unavailable, state-of-the-art facility for Australian scientists to define precisely how changes in cellular redox state contribute to biological processes relevant to health and diseases. The facility will uniquely complement, and in many cases integrate with existing facilities in this area of research in Australia. It will act as a platform for major national and inter ....Oxidative stress bioanalytical facility. The primary national benefit of this application is that it will provide a currently unavailable, state-of-the-art facility for Australian scientists to define precisely how changes in cellular redox state contribute to biological processes relevant to health and diseases. The facility will uniquely complement, and in many cases integrate with existing facilities in this area of research in Australia. It will act as a platform for major national and international research collaborations, develop cutting-edge technology and unique local skills, and contribute to Australia maintaining a leading position in redox-related research in biology and medicine. In doing so, the facility will increase the likelihood of gaining future, value-adding funding.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC170100035
Funder
Australian Research Council
Funding Amount
$4,743,710.00
Summary
ARC Training Centre for Innovation in Biomedical Imaging Technology. The ARC Training Centre for Innovation in Biomedical Imaging Technology expects to train 20 industry-ready innovation scientists who will undertake industry-driven research in the development and application of novel diagnostics, therapeutics and theranostics. They will inform changes in regulatory policy that support industry growth. The Centre will build multidisciplinary links between researchers and within industry to devel ....ARC Training Centre for Innovation in Biomedical Imaging Technology. The ARC Training Centre for Innovation in Biomedical Imaging Technology expects to train 20 industry-ready innovation scientists who will undertake industry-driven research in the development and application of novel diagnostics, therapeutics and theranostics. They will inform changes in regulatory policy that support industry growth. The Centre will build multidisciplinary links between researchers and within industry to develop ‘smart’ probes and ‘smart’ scanning, harnessing the digital revolution for better, cost effective diagnostic imaging and improved health outcomes.Read moreRead less